Availability

There are currently 7 dedicated products on the market:
- Gymiso® - 200µg tablets, France
- Prostokos® - 25µg vaginal tablets, Brazil
- Vagiprost® - 25µg vaginal tablets, Egypt
- U-Miso 200µg manufactured by U-Liang Ltd, Taiwan.
- Misoprost 600® - 600µg vaginal tablets, India (indicated for PPH prophylaxis)
- Zitotec® - 200µg or 100µg tablets, India
- Isprelor™ - 25µg vaginal tablets, UK
Two phase III clinical trials of Isprelor® have been completed. The results have been presented and published in the British Journal of Obstetrics and Gynaecology (BJOG-2008 Sep; 115(10):1279-88). Once clinical development is completed application for European Marketing Authorisation is planned.
